Latest agbiotech News | Page 5

AusBiotech launches National Cell and Gene Manufacturing Blueprint
Industry-led cell and gene manufacturing strategy to develop Australia as APAC hub launched
Henry Schein Medical expands distribution partnership with Lumos Diagnostics
Actinogen CMO presents academic poster to Alzheimer’s Association International Conference
Sensible approach for medtech clinical trials
Pharmaxis reports positive analysis of data from phase 2 PXS-5505 study
Victoria invites expressions of interest for Industry R&D Infrastructure Fund grants
Early-Stage Innovation Forum opens
Lumos completes placement and launches share purchase plan
First cohort dosed in RECCE 327 rapid infusion UTI clinical trial
Build your profile through BiotechDispatch
Moderna submits RSV vaccine to global regulatory agencies
Genetic discovery could help prevent irreversible blindness in people with glaucoma
AusBioNSW General Manager appointed
Cynata Therapeutics announces CEO succession and board changes
Nutromics to progress wearable diagnostic platform with latest capital raise
Takeda’s COCKPI-T programme calls for applications
Neuren opens first site in US for Prader-Willi syndrome Phase 2 trial
AusBiotech calls for journal articles
Imagion Biosystems announces appointment of new CEO
The new ‘Jumar Bioincubator’ calls for biotechnology start-ups
Top performing ASX life science companies
First patient dosed in study of TLX250-CDx exploring indication expansion
AVITA Medical announces FDA approval of RECELL for skin repigmentation in vitiligo patients
WEHI’s Professor Doug Hilton appointed chief executive of CSIRO
Vaxxas opens needle-free vaccine manufacturing site and global HQ in Brisbane
AZD0466 clinical data presented by AstraZeneca at international congress
Views sought on coordination of research funds
Telix opens European radiopharmaceutical production facility
Anteris Technologies reports positive 30 day data from first-in-human study
Former AusBiotech CEO awarded King’s Birthday Honour
Vaxxas appoints former Pfizer executive as chief medical officer
Neuren Pharmaceuticals receives milestone payment from US partner
Clinical Trials One Stop Shop report released
Starpharma announces that Viraleze approved in Malaysia
Anatara Lifesciences updates on GaRP irritable bowel syndrome trial
Aravax launches new Phase 2 trial of peanut allergy candidate
Team Australia shines at BIO 2023
Optiscan Imaging launches entitlement offer to raise $16.7 million
Zelira Therapeutics announces the appointment of new non-executive director
Chimeric Therapeutics announces new trial for CHM 1101 in glioblastoma
New ESG guide seeks industry feedback
Dr Robert Lin named named new CEO of GreenLight Clinical
Kazia Therapeutics participates in ‘Cancer Moonshot Brain Cancers’ forum
Best early-stage project at awarded at AusMedtech 2023
Pharmaxis reports positive results from trial of PXS‐6302
CSIRO launches free SME programme
Oncosil Medical announces first patient treatment in Italy